Indefinite Delivery Contract 36E79726D0020
- Not listed
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the VA National Acquisition Center on February 12, 2022, with a ceiling value of $40.48 million for the supply of lisinopril tablets in 23 different strengths and package sizes. The contract encompasses a one-year base period (February 12, 2022 to February 11, 2023) with four one-year option periods, extending through February 11, 2027, with the fourth option year having been exercised. This procurement was...
- DR Reddy's Laboratories, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to supply Metoprolol Succinate Sustained Action tablets. The contract, valued at $34.17 million, was awarded on April 29, 2026, with a one-year base period (April 29, 2026 to April 28, 2027) and four one-year options, creating a potential five-year performance window through April 28, 2031. The procurement serves multiple federal agencies...
- Exelan Pharmaceuticals Inc., headquartered in Boca Raton, Florida, was awarded a Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) by the Department of Veterans Affairs' Veterans Integrated Service Network 12 on September 15, 2020, with a contract ceiling value of $3.08 billion and ultimate completion date of September 14, 2026. This multiple-award, unrestricted competitive procurement established a pre-competed schedule vehicle enabling the Department of...
- This Indefinite Delivery Contract awards Exelan Pharmaceuticals Inc., headquartered in Boca Raton, Florida, a single-award agreement for the supply of Ramipril capsules to the Department of Veterans Affairs through its National Acquisition Center. The contract carries a ceiling value of $12.8 million and was awarded on March 14, 2022, with an initial base period extending from March 14, 2022, through March 13, 2023, followed by four one-year option periods. The contract was issued without...
- This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $4,792,297.44 and a period of performance from December 20, 2024 to December 19, 2026, with a one-year base period and four one-year option periods. The contract is intended to provide an uninterrupted source of supply for...
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Escitalopram Oxalate tablets, a selective serotonin reuptake inhibitor commonly used in the treatment of depression and anxiety disorders. The contract, effective March 17, 2024, carries a ceiling value of $48.4 million and establishes a base performance period of one year (March 17, 2024 to March 16, 2025) with four one-year...
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the procurement of Nadolol tablets in 20mg, 40mg, and 80mg dosages, with an estimated annual usage of 10,152 bottles, 8,817 bottles, and 2,349 bottles respectively. The contract is a single-award, unrestricted procurement with a ceiling value...
- The federal contract IDV award is for the delivery of Topiramate tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, unrestricted contract was issued by the VA National Acquisition Center, with a total ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025. The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical...
- This Indefinite Delivery Contract (IDC) with a ceiling value of $5,592,523.40 was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, which has a period of performance through June 7, 2026, is for the manufacture and distribution of various pharmaceutical products, including generic medications such as ibuprofen, citalopram, oseltamivir phosphate, and alfuzosin HCl. Exelan...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Exelan Pharmaceuticals Inc. effective June 20, 2022, with a ceiling value of $15.58 million and ultimate completion date of June 19, 2025. The contract establishes a framework for the provision of ibuprofen tablets and related pharmaceutical repackaging services to support the VA's Pharmaceutical Repackaging Program, which consolidates bulk pharmaceutical products into...
Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Metoprolol Tartrate Tablets to multiple federal healthcare systems. The contract, awarded May 8, 2026, carries a ceiling value of $13.95 million and establishes an initial one-year base period (May 8, 2026 through May 7, 2027) with four one-year option periods, providing potential contract continuity through May 2031. The procurement supports pharmaceutical distribution requirements across the Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through their respective pharmaceutical prime vendor programs. Metoprolol Tartrate Tablets will be supplied in three strengths (25 milligrams, 50 milligrams, and 100 milligrams) in multiple package configurations (100, 500, and 1,000 tablets per bottle), with estimated annual requirements ranging from 2,715 to 174,928 bottles depending on specific strength and package combination. Exelan will perform substantially all work at its Boca Raton, Florida facility, with products distributed to designated federal agency delivery locations. This award represents a new contract vehicle under the unrestricted pharmaceutical procurement (RFP 36E79725R0071) and does not utilize any set-aside designations, allowing full and open competition. Metoprolol Tartrate, a beta-blocker used in cardiovascular treatment protocols, aligns with the federal healthcare systems' therapeutic pharmaceutical requirements and establishes Exelan as the sole-source supplier for this medication across the multi-agency customer base. The single-award structure ensures procurement continuity and supply chain stability for this critical cardiac medication, consistent with the Department of Veterans Affairs' strategic pharmaceutical supplier management approach and Exelan's established role as a primary vendor within the federal pharmaceutical procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/4/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Metoprolol Tartrate Tablets | 36E79725R0071 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 10/9/25, 4:17 PM | |
6505--Metoprolol Tartrate Tablets | 36E79725R0071 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 10/30/25, 9:02 AM | |
6505--Metoprolol Tartrate IR Tablets Effective 5/8/2026 - 5/7/2027 | 36E79725R0071 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 2/4/26, 4:18 PM |